Mei Li
Scientist at the Pediatrics Research Institute of Children's Hospital of Soochow University studying brain injury, who contributed to a study of how PIP4K2A protects the brain after stroke
Pediatrics Research Institute · Soochow Key Laboratory of Prevention and Treatment of Child Brain Injury · Children's Hospital of Soochow University · Suzhou, Jiangsu, China
Mei Li is based at the Pediatrics Research Institute, Children's Hospital of Soochow University, in a group focused on mechanisms of hypoxic-ischemic and developmental brain injury. She is a co-author on the Suzhou team's work identifying PIP4K2A as a protective factor in cerebral ischemia/reperfusion injury.
PubMed also credits Li as the corresponding author of a 2026 study of Trim47 protecting the neonatal blood-brain barrier, a 2025 study of FAM20C in hypoxic-ischemic brain damage from the same institute, and a 2026 paper with a dual Soochow/Massachusetts General Hospital affiliation — pointing to an active, pediatrics-focused neuroscience researcher with an international collaboration.
Milestones in the Atlas
| Year | Evidence | Study |
|---|---|---|
| 2026 | A | PIP4K2A Attenuates Cerebral Ischemia/Reperfusion Injury by Reducing the TRIB3-p62 Complex Burden and Modulating AKT/mTOR Signaling. MA2026 Co-author from the Children's Hospital of Soochow University Pediatrics Research Institute on the PIP4K2A/TRIB3-p62/AKT-mTOR stroke-protection study. |
Co-authors in the Atlas
People with a profile here who share at least one study with Mei Li.
- Shuai Yu Neurology researcher who contributed to a study showing that the lipid kinase PIP4K2A protects the brain after ischaemic stroke by relieving a block on autophagy and boosting AKT/mTOR signalling
- Xiaotian Yu Stroke neurology researcher who contributed to a study of how PIP4K2A limits brain injury after ischaemia and reperfusion through the TRIB3–p62 and AKT–mTOR pathways